Search

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

… Wednesday, February 21, 2018 Summary In this interview, Mark Robson, Chief of the Breast Medicine Service at Memorial Sloan Kettering, discusses olaparib, the latest drug approved for breast cancer, and how genetic testing can lead to new targeted therapies. Last month, the US Food and Drug Administration

Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite early-stage drug discovery of innovative new therapies. Under this expansion, Tri-I TDI will extend its current relationship with its industry partner, Takeda Pharmaceutical Company, Ltd. from the realm of small molecule discovery into the new research area of antibody drug discovery. All three institutions will benefit from Tri-I TDI’s expansion.

… Thursday, June 16, 2016 Memorial Sloan Kettering Cancer Center (MSK), The Rockefeller University, and Weill Cornell Medicine today announced that they will expand the focus of the successful Tri-Institutional Therapeutics Discovery Institute, Inc. (Tri-I TDI), a partnership established in 2013 to expedite

Read about a CAR T cell therapy that appears effective against light chain (AL) amyloidosis.

… Sunday, December 7, 2025 VIDEO | 02:47 Watch How CAR T Cell Therapy Eliminated a Patient’s Rare Blood Disease Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the scientists

The scientific world lost one of its greats this week. Here, we reflect on his influence.

… Friday, January 11, 2019 John Mendelsohn John Mendelsohn John Mendelsohn Dr. Mendelsohn in his lab at MSK John Mendelshon Dr. Mendelsohn in his lab at MSK Summary Former MSK physician-scientist John Mendelsohn, who served the institution in multiple roles from 1985 to 1996, died on January 7 from brain

In recognition of Breast Cancer Awareness Month, MSK shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers.

… Wednesday, October 20, 2021 In recognition of Breast Cancer Awareness Month, Memorial Sloan Kettering Cancer Center (MSK) shared four stories about new developments and advances in breast cancer prevention, research and treatment being conducted by MSK clinicians and researchers. The COVID-19 pandemic

In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included.

… Wednesday, December 4, 2019 Summary In an international study led by MSK, researchers reported finding key mutations driving the disease histiocytosis for nearly all of the people included. Histiocytoses are a group of blood diseases that are diagnosed in only a few hundred people in the United States

New MSK research finds the TCA cycle’s waste-management function may present an opportunity against cancer; shows how microplastics impair immune ‘housekeeping’ functions; reveals the way the protein TOX plays different roles in different immune cells; and identifies a new combination approach for treating advanced kidney cancer after immunotherapy.

… Monday, March 2, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) shows how microplastics impair immune ‘housekeeping’ functions; finds the TCA cycle’s waste-management function may present an opportunity against cancer; reveals the way the protein TOX plays different roles in different

Infectious disease expert Mini Kamboj shares what people with cancer should know about COVID-19 and how MSK is keeping our patients and staff safe

… Wednesday, April 1, 2020 By Jim Stallard This story was updated on April 27, 2020. COVID-19 emerged as a major threat to public health in the United States in early 2020. Memorial Sloan Kettering Chief Medical Epidemiologist and infectious disease expert Mini Kamboj shares some facts about COVID-19,

To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side.

… Tuesday, March 15, 2022 To ensure greater access to cancer care for all New Yorkers and patients who come from around the globe, Memorial Sloan Kettering Cancer Center (MSK) today announced plans to build a new, state-of-the-art cancer care Pavilion on its main campus on the Upper East Side. The Centers

This article is Part 2 of our three-part series on MSK-led advances for improving outcomes for patients with rare head and neck cancers.

… Friday, March 22, 2024 Part 2: Rare Thyroid Cancers This article is Part 2 of our three-part series on MSK-led advances for improving outcomes for patients with rare head and neck cancers. Part 2 summarizes MSK’s leadership and expertise in developing new therapeutic options for patients with rare thyroid